Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal

Interest in amyotrophic lateral sclerosis (ALS) biomarkers has grown exponentially over the course of the last 25 years, with great hope that they might serve as tools to facilitate the development of meaningful therapies for this otherwise inexorably progressive and invariably fatal disease. Effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Benatar, Michael, Wuu, Joanne, Turner, Martin R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Update
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10316774/
https://www.ncbi.nlm.nih.gov/pubmed/36310538
http://dx.doi.org/10.1093/brain/awac394

Ejemplares similares

Ejemplares similares